Pharma BD Deal Intelligence
Teva Pharmaceutical Industries Ltd. / Auspex Pharmaceuticals
2015 · Acquisition/Merger · $3.5B · Complete
Announcement Sentiment
63
Positive
Outcome Score
86
Worked — the deal delivered on its rationale.
Teva acquired Auspex Pharmaceuticals for $3.5B for CNS drug portfolio.
Key facts
- Announced Mar 30, 2015
- Closed May 05, 2015
- Deal value $3.5B
- Deal type Acquisition/Merger
- Therapeutic area Neurology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals